Search research articles
Contact Us
Filters
Showing results (171-180 of 205) with videos related to
Page
of 21
Sort By:
Journal of Hepatology
|
July 13, 2025
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial
Thierry Thévenot, Laure Elkrief, Christophe Bureau, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma
Jean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
The Lancet. Oncology
|
December 13, 2021
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study
Eric Trépo, Stefano Caruso, Jie Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world data
Claudia Campani, Ju Hyun Shim, Mohamed Bouattour, et al.
The Journal of Pathology
|
February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2
Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
The American Journal of Gastroenterology
|
September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Gastroenterology
|
August 26, 2018
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
Richard Moreau, Laure Elkrief, Christophe Bureau, et al.
JHEP Reports : Innovation in Hepatology
|
June 11, 2026
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma
Anne Victoire Odent, Claudia Campani, Mohamed Bouattour, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Pierre Nahon, Marianne Ziol, Long Pan, et al.
Hepatology (Baltimore, Md.)
|
April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis
Jean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 205) with videos related to
Sort By:
Page
of 21
Journal of Hepatology
|
July 13, 2025
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial
Thierry Thévenot, Laure Elkrief, Christophe Bureau, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 3, 2025
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma
Jean-Charles Nault, Claudia Campani, Theo Z Hirsch, et al.
The Lancet. Oncology
|
December 13, 2021
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study
Eric Trépo, Stefano Caruso, Jie Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 20, 2026
Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world data
Claudia Campani, Ju Hyun Shim, Mohamed Bouattour, et al.
The Journal of Pathology
|
February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2
Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
The American Journal of Gastroenterology
|
September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Gastroenterology
|
August 26, 2018
Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis
Richard Moreau, Laure Elkrief, Christophe Bureau, et al.
JHEP Reports : Innovation in Hepatology
|
June 11, 2026
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma
Anne Victoire Odent, Claudia Campani, Mohamed Bouattour, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2026
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with BCLC a hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Pierre Nahon, Marianne Ziol, Long Pan, et al.
Hepatology (Baltimore, Md.)
|
April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis
Jean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.
Page
of 21